CRISPR Research Funded

The AHC Foundation is delighted to announce a partnership with Dr. David Liu’s laboratory at the Broad Institute and Harvard University to investigate gene editing as a potential therapy for AHC. The work of Dr. Liu and his collaborators has been groundbreaking. His recent work on the use of base editing in mice to treat progeria is an exciting demonstration of the promise base editing holds for our children and their families. We are proud to be on the cutting edge of science, and excited for the future of AHC research.

Our continued collaboration with CureAHC and Hope for Annabel has brought us closer to our goal faster than we could have done alone. We are grateful for this partnership, and are looking forward to the end of ahc.

https://liugroup.us/research-overview/genome-editing/

#ENDAHC#ONEINAMILLION#RAREDISEASE#AHCF#AHCstrong